Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dementia epidemiology.

Walter A Kukull1, James D Bowen

  • 1Department of Epidemiology, University of Washington, Box 357236, Seattle, WA 98195-7286, USA. kukull@u.washington.edu

The Medical Clinics of North America
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Brain communications·2026
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

Sex-specific genetic drivers of memory, executive functioning and language in older adults.

Brain : a journal of neurology·2026
Same author

Genetic modifiers of APOE-ε4-associated cognitive decline.

Nature communications·2026
Same author

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Determining dementia incidence and prevalence is challenging due to diagnostic difficulties. Understanding genetic and environmental factors is crucial for future prevention strategies and public health initiatives.

Area of Science:

  • Epidemiology
  • Neuroscience
  • Genetics

Background:

  • Dementia diagnosis and prevalence estimation face significant challenges.
  • Dementia imposes a substantial societal burden.
  • Diagnostic inaccuracies and gradual disease onset complicate risk factor identification.

Purpose of the Study:

  • To highlight the difficulties in determining dementia incidence and prevalence.
  • To discuss the influence of diagnostic challenges on risk factor research.
  • To emphasize the importance of genetic and environmental interactions in dementia pathogenesis.

Main Methods:

  • Review of current epidemiological challenges in dementia research.
  • Analysis of diagnostic limitations impacting risk and survival factor assessment.

Related Experiment Videos

  • Exploration of genetic and environmental interactions in dementia.

    • Main Results:

    • Dementia incidence and prevalence are difficult to ascertain accurately.
    • Cognitive reserve and factors influencing brain development may delay Alzheimer's Disease (AD) onset or diagnosis.
    • Genetic factors, particularly those interacting with environmental exposures, are increasingly recognized in dementia pathogenesis.

    Conclusions:

    • Accurate dementia determination requires refined epidemiological tools.
    • Future research must integrate molecular advances with traditional epidemiology.
    • Prevention strategies should address genetic predispositions and environmental contexts.